Bactiguard Holding Logo

Bactiguard Holding

ISIN: SE0005878741 | Ticker: BACTI | LEI: 549300PAEBW7IAMOSO21
Sector: Health Care – Sub-Industry: Health Care Equipment
Country: Sweden

About Bactiguard Holding

Company Description

Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission, we develop and supply infection prevention solutions which reduce the risk of infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large.

The Bactiguard technology is based on a thin noble metal alloy coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Urinary catheters with Bactiguard's coating are market leaders in the USA and Japan through our licensing partner BD. Bactiguard's product portfolio also includes a non-alcoholic product line for wound care and disinfection. It effectively kills viruses, bacteria and fungi while being biocompatible, pH neutral and tissue friendly.

Year founded

2005

Headquarters

Alfred Nobels Allé 150, 14621 Tullinge – Sweden

Financial statements

Download as Excel
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 675,221,000.00 849,289,000.00 807,703,000.00
Noncurrent Assets N/A 563,875,000.00 528,947,000.00 499,344,000.00
Property Plant And Equipment N/A 108,172,000.00 100,646,000.00 99,629,000.00
Buildings N/A 13,509,000.00 14,132,000.00 15,097,000.00
Machinery N/A 7,981,000.00 10,465,000.00 18,027,000.00
Goodwill N/A 245,411,000.00 247,485,000.00 250,466,000.00
Brand Names N/A 26,155,000.00 26,015,000.00 25,875,000.00
Recipes Formulae Models Designs And Prototypes N/A 149,652,000.00 124,245,000.00 98,838,000.00
Other Noncurrent Receivables N/A 1,708,000.00 1,674,000.00 1,310,000.00
Deferred Tax Assets N/A N/A N/A 1,785,000.00
Current Assets N/A 111,346,000.00 320,342,000.00 308,359,000.00
Inventories N/A 34,161,000.00 36,064,000.00 44,367,000.00
Current Trade Receivables N/A 49,642,000.00 43,157,000.00 47,126,000.00
Other Current Receivables N/A 6,738,000.00 7,162,000.00 7,285,000.00
Cash and cash equivalents 22,878,000.00 9,886,000.00 217,587,000.00 197,727,000.00
Equity And Liabilities N/A 675,221,000.00 849,289,000.00 807,703,000.00
Equity N/A 373,349,000.00 541,450,000.00 495,709,000.00
Issued Capital N/A 839,000.00 876,000.00 876,000.00
Retained Earnings N/A -327,492,000.00 -386,265,000.00 -439,141,000.00
Additional Paidin Capital N/A 707,805,000.00 930,680,000.00 930,680,000.00
Equity Attributable To Owners Of Parent N/A 373,349,000.00 541,450,000.00 495,709,000.00
Liabilities N/A 301,873,000.00 307,839,000.00 311,994,000.00
Noncurrent Liabilities N/A 266,259,000.00 245,628,000.00 227,784,000.00
Deferred Tax Liabilities N/A 11,980,000.00 7,320,000.00 0.00
Longterm Borrowings N/A 188,016,000.00 180,663,000.00 179,265,000.00
Current Liabilities N/A 35,614,000.00 62,211,000.00 84,210,000.00
Trade And Other Current Payables To Trade Suppliers N/A 8,801,000.00 27,904,000.00 33,821,000.00
Current Accruals And Current Deferred Income Including Current Contract Liabilities N/A N/A 19,413,000.00 33,052,000.00
Other Current Payables N/A 3,991,000.00 5,242,000.00 6,422,000.00
Line item in (sek) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 172,315,000.00 169,486,000.00 223,560,000.00
Other Income 13,711,000.00 9,562,000.00 29,935,000.00
Changes In Inventories Of Finished Goods And Work In Progress -4,700,000.00 -3,057,000.00 -3,890,000.00
Other Work Performed By Entity And Capitalised 3,959,000.00 2,412,000.00 540,000.00
Raw Materials And Consumables Used 43,853,000.00 44,152,000.00 47,846,000.00
Employee Benefits Expense 67,188,000.00 84,692,000.00 105,060,000.00
Depreciation And Amortisation Expense 44,293,000.00 47,004,000.00 49,240,000.00
Other Expense By Nature 7,659,000.00 6,756,000.00 28,214,000.00
Profit Loss From Operating Activities -17,638,000.00 -54,188,000.00 -55,667,000.00
Finance Income 2,240,000.00 7,008,000.00 12,716,000.00
Finance Costs 26,535,000.00 16,072,000.00 16,904,000.00
Profit Loss Before Tax -41,933,000.00 -63,252,000.00 -59,855,000.00
Profit (loss) -38,388,000.00 -58,773,000.00 -52,876,000.00
Profit Loss Attributable To Owners Of Parent -38,388,000.00 -58,773,000.00 -52,876,000.00
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A -38,388,000.00 -58,773,000.00 -52,876,000.00
Adjustments For Decrease Increase In Inventories N/A -5,054,000.00 -3,720,000.00 -7,936,000.00
Adjustments For Decrease Increase In Other Operating Receivables N/A 873,000.00 -4,105,000.00 4,948,000.00
Adjustments For Increase Decrease In Trade Account Payable N/A -730,000.00 17,993,000.00 4,113,000.00
Adjustments For Increase Decrease In Other Operating Payables N/A -10,023,000.00 7,418,000.00 15,343,000.00
Adjustments For Depreciation And Amortisation Expense N/A 44,293,000.00 47,004,000.00 49,240,000.00
Other Adjustments For Noncash Items N/A 5,415,000.00 1,574,000.00 207,000.00
Cash Flows From Used In Operating Activities N/A 702,000.00 7,256,000.00 3,062,000.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 41,663,000.00 0.00 N/A
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 10,447,000.00 4,585,000.00 9,842,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 4,903,000.00 2,710,000.00 1,076,000.00
Cash Flows From Used In Investing Activities N/A -57,013,000.00 -7,295,000.00 -10,918,000.00
Proceeds From Issuing Shares N/A 0.00 228,000,000.00 0.00
Proceeds From Borrowings Classified As Financing Activities N/A 43,441,000.00 0.00 N/A
Repayments Of Borrowings Classified As Financing Activities N/A 1,376,000.00 562,000.00 900,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 5,498,000.00 8,618,000.00 12,809,000.00
Other Inflows Outflows Of Cash Classified As Financing Activities N/A 781,000.00 -4,137,000.00 -1,144,000.00
Cash Flows From Used In Financing Activities N/A 46,204,000.00 205,827,000.00 -13,892,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A -10,107,000.00 205,788,000.00 -21,748,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -2,886,000.00 1,913,000.00 1,888,000.00
Cash and cash equivalents 22,878,000.00 9,886,000.00 217,587,000.00 197,727,000.00

Please note that some sums might not add up.

Filings & Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume
22.12.23 Thomas von Koch Other Other SEK 247,838.24
11.08.23 Mikael Sander Other Buy SEK 46,760.00
12.05.23 Mikael Sander Other Buy SEK 356,720.00
08.05.23 Mikael Sander Other Buy SEK 343,280.00
08.05.23 Thomas von Koch Other Other SEK 123,919.12
08.05.23 Mikael Sander Other Buy SEK 123,919.12
02.05.23 Thomas von Koch Other Buy SEK 17,092.50
28.04.23 Thomas von Koch Other Buy SEK 24,343,955.51
14.12.22 Thomas von Koch Other Other SEK 1,000,004.10
07.11.22 TomEnterprise Public Capital AB Other Buy SEK 35,686,980.00

Capital markets information

ISIN

SE0005878741

LEI

549300PAEBW7IAMOSO21

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Equipment

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.